An international workshop co-led by University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., laid the foundation for developing guidance for the clinical care of people at elevated genetic risk for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Read the full article here.
Recent Posts
- Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
- July 26, 2026: Miami Marlins Game
- Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
- The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
- CReATe Author Series Ep. 18 – Dr. Michael Benatar on MMI as a prodromal stage of ALS
Recent Comments